These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32502649)

  • 1. Impact of direct-to-consumer genetic testing on Australian clinical genetics services.
    Millward M; Tiller J; Bogwitz M; Kincaid H; Taylor S; Trainer AH; Lacaze P
    Eur J Med Genet; 2020 Sep; 63(9):103968. PubMed ID: 32502649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Australians' perspectives on support around use of personal genomic testing: Findings from the Genioz study.
    Metcalfe SA; Hickerton C; Savard J; Stackpoole E; Tytherleigh R; Tutty E; Terrill B; Turbitt E; Gray K; Middleton A; Wilson B; Newson AJ; Gaff C
    Eur J Med Genet; 2019 May; 62(5):290-299. PubMed ID: 30439534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Awareness, attitudes and perspectives of direct-to-consumer genetic testing in Greece: a survey of potential consumers.
    Mavroidopoulou V; Xera E; Mollaki V
    J Hum Genet; 2015 Sep; 60(9):515-23. PubMed ID: 26040209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding and perception of direct-to-consumer genetic testing in Hong Kong.
    Hui VCC; Li HC; Chow JHK; Ng CSC; Lui CYW; Fung JLF; Mak CCY; Chung BHY; Lau KK
    J Genet Couns; 2021 Dec; 30(6):1640-1648. PubMed ID: 33938075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct-to-Consumer Genomic Testing Through an Ethics Lens: Oncology Nursing Considerations.
    VerStrate CA; Mahon SM
    Clin J Oncol Nurs; 2023 Jul; 27(4):380-388. PubMed ID: 37677769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Third-Party Genetic Interpretation Tools: A Mixed-Methods Study of Consumer Motivation and Behavior.
    Nelson SC; Bowen DJ; Fullerton SM
    Am J Hum Genet; 2019 Jul; 105(1):122-131. PubMed ID: 31204012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public reactions to direct-to-consumer genetic health tests: A comparison across the US, UK, Japan and Australia.
    Charbonneau J; Nicol D; Chalmers D; Kato K; Yamamoto N; Walshe J; Critchley C
    Eur J Hum Genet; 2020 Mar; 28(3):339-348. PubMed ID: 31645768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who are you going to call? Primary care patients' disclosure decisions regarding direct-to-consumer genetic testing.
    Wasson K; Cherny S; Sanders TN; Hogan NS; Helzlsouer KJ
    Narrat Inq Bioeth; 2014; 4(1):53-68. PubMed ID: 24748260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct-to-Consumer Nutrigenetics Testing: An Overview.
    Floris M; Cano A; Porru L; Addis R; Cambedda A; Idda ML; Steri M; Ventura C; Maioli M
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32098227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumer use and response to online third-party raw DNA interpretation services.
    Wang C; Cahill TJ; Parlato A; Wertz B; Zhong Q; Cunningham TN; Cummings JJ
    Mol Genet Genomic Med; 2018 Jan; 6(1):35-43. PubMed ID: 29471590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informed choice in direct-to-consumer genetic testing (DTCGT) websites: a content analysis of benefits, risks, and limitations.
    Singleton A; Erby LH; Foisie KV; Kaphingst KA
    J Genet Couns; 2012 Jun; 21(3):433-9. PubMed ID: 22194036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct to consumer genetic and genomic testing with associated implications for advanced nursing practice.
    Aleman KM; Chipman M; Peck JL; Hughes AK; Murphey C
    J Am Assoc Nurse Pract; 2021 Jun; 34(2):381-388. PubMed ID: 34107502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct-to-Consumer Genetic Testing: Helping Patients Make Informed Choices.
    Mahon SM
    Clin J Oncol Nurs; 2018 Feb; 22(1):33-36. PubMed ID: 29350705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. May direct-to-consumer genetic testing have an impact on general practitioners' daily practice? a cross-sectional study of patients' intentions towards this approach.
    Cohidon C; Cardinaux R; Cornuz J; Chenal R; Desvergne B; Guessous I; Cerqui D; Widmer D
    BMC Fam Pract; 2021 Apr; 22(1):79. PubMed ID: 33902442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary care patients' views and decisions about, experience of and reactions to direct-to-consumer genetic testing: a longitudinal study.
    Wasson K; Sanders TN; Hogan NS; Cherny S; Helzlsouer KJ
    J Community Genet; 2013 Oct; 4(4):495-505. PubMed ID: 23832288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct-to-consumer genetic testing: where and how does genetic counseling fit?
    Middleton A; Mendes Á; Benjamin CM; Howard HC
    Per Med; 2017 May; 14(3):249-257. PubMed ID: 29767582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends and Gaps in Awareness of Direct-to-Consumer Genetic Tests From 2007 to 2014.
    Apathy NC; Menser T; Keeran LM; Ford EW; Harle CA; Huerta TR
    Am J Prev Med; 2018 Jun; 54(6):806-813. PubMed ID: 29656919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are providers prepared for genomic medicine: interpretation of Direct-to-Consumer genetic testing (DTC-GT) results and genetic self-efficacy by medical professionals.
    McGrath SP; Walton N; Williams MS; Kim KK; Bastola K
    BMC Health Serv Res; 2019 Nov; 19(1):844. PubMed ID: 31760949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct-to-consumer genetic testing with third party interpretation: beware of spurious results.
    Horton R; Crawford G; Freeman L; Fenwick A; Lucassen A
    Emerg Top Life Sci; 2019 Nov; 3(6):669-674. PubMed ID: 32915220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct-to-consumer DNA testing and the GP.
    Trent R
    Aust Fam Physician; 2014 Jul; 43(7):436-9. PubMed ID: 25006602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.